Literature DB >> 22923028

The role of menstrual cycle phase and anxiety sensitivity in catastrophic misinterpretation of physical symptoms during a CO(2) challenge.

Yael I Nillni1, Kelly J Rohan, Michael J Zvolensky.   

Abstract

The current study examined the interactive effects of anxiety sensitivity (AS; fear of anxiety and anxiety-related sensations) and menstrual cycle phase (premenstrual phase vs. follicular phase) on panic-relevant responding (i.e., cognitive and physical panic symptoms, subjective anxiety, and skin conductance level). Women completed a baseline session and underwent a 3-min 10 % CO(2)-enriched air biological challenge paradigm during her premenstrual and follicular menstrual cycle phases. Participants were 55 women with no current or past history of panic disorder recruited from the general community (M (age) = 26.18, SD = 8.9) who completed the biological challenge during both the premenstrual and follicular cycle phases. Results revealed that women higher on AS demonstrated increased cognitive panic symptoms in response to the challenge during the premenstrual phase as compared to the follicular phase, and as compared to women lower on AS assessed in either cycle phase. However, the interaction of AS and menstrual cycle phase did not significantly predict physical panic attack symptoms, subjective ratings of anxiety, or skin conductance level in response to the challenge. Results are discussed in the context of premenstrual exacerbations of cognitive, as opposed to physical, panic attack symptoms for high AS women, and the clinical implications of these findings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22923028      PMCID: PMC3495998          DOI: 10.1007/s00737-012-0302-2

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


  53 in total

1.  Daily Record of Severity of Problems (DRSP): reliability and validity.

Authors:  J Endicott; J Nee; W Harrison
Journal:  Arch Womens Ment Health       Date:  2005-09-20       Impact factor: 3.633

2.  Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases.

Authors:  J M Le Mellédo; S Merani; D Koszycki; F Bellavance; R Palmour; J Gutkowska; S Steinberg; D G Bichet; J Bradwejn
Journal:  Neuropsychopharmacology       Date:  1999-01       Impact factor: 7.853

3.  Anxiety Sensitivity Amelioration Training (ASAT): a longitudinal primary prevention program targeting cognitive vulnerability.

Authors:  Norman B Schmidt; A Meade Eggleston; Kelly Woolaway-Bickel; Kathleen Kara Fitzpatrick; Michael W Vasey; J Anthony Richey
Journal:  J Anxiety Disord       Date:  2006-08-04

4.  Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: a possible model of premenstrual dysphoric disorder.

Authors:  Sheryl S Smith; Yevgeniy Ruderman; Cheryl Frye; Gregg Homanics; Maoli Yuan
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

5.  Anxiety sensitivity: prospective prediction of panic attacks and Axis I pathology.

Authors:  Norman B Schmidt; Michael J Zvolensky; Jon K Maner
Journal:  J Psychiatr Res       Date:  2006-09-07       Impact factor: 4.791

6.  Anxiety sensitivity and panic attacks: a 1-year longitudinal study.

Authors:  Wen Li; Richard E Zinbarg
Journal:  Behav Modif       Date:  2007-03

7.  Diathesis stress model for panic-related distress: a test in a Russian epidemiological sample.

Authors:  Michael J Zvolensky; Roman Kotov; Anna V Antipova; Norman B Schmidt
Journal:  Behav Res Ther       Date:  2005-04

Review 8.  Sex-sensitive tasks in men and women: a search for performance fluctuations across the menstrual cycle.

Authors:  L K Epting; W H Overman
Journal:  Behav Neurosci       Date:  1998-12       Impact factor: 1.912

9.  Affect intensity: association with anxious and fearful responding to bodily sensations.

Authors:  Anka A Vujanovic; Michael J Zvolensky; Laura E Gibson; Thomas R Lynch; Ellen W Leen-Feldner; Matthew T Feldner; Amit Bernstein
Journal:  J Anxiety Disord       Date:  2006

10.  Differences in symptom scores and health outcomes in premenstrual syndrome.

Authors:  Jeff E Borenstein; Bonnie B Dean; Eckhard Leifke; Paul Korner; Kimberly A Yonkers
Journal:  J Womens Health (Larchmt)       Date:  2007-10       Impact factor: 2.681

View more
  14 in total

1.  Emotional distress and tobacco demand during the menstrual cycle in female smokers.

Authors:  Samantha G Farris; Ana M Abrantes; Michael J Zvolensky
Journal:  Cogn Behav Ther       Date:  2018-07-31

2.  Examination of the stability of the anxiety sensitivity index across the menstrual cycle in trauma-exposed women with and without PTSD.

Authors:  Yael I Nillni; Kim A Arditte Hall; Kirsten J Langdon; Suzanne L Pineles
Journal:  Anxiety Stress Coping       Date:  2019-08-27

3.  Cannabis Use and Anxiety Sensitivity in Relation to Physical Health and Functioning in post-9/11 Veterans.

Authors:  Kate L Stewart; Samantha G Farris; Kristina M Jackson; Brian Borsari; Jane Metrik
Journal:  Cognit Ther Res       Date:  2018-08-09

4.  Conditioned physiological reactivity and PTSD symptoms across the menstrual cycle: Anxiety sensitivity as a moderator.

Authors:  Joseph K Carpenter; Laura Bragdon; Suzanne L Pineles
Journal:  Psychol Trauma       Date:  2021-10-04

5.  The role of perceived control over anxiety in prospective symptom reports across the menstrual cycle.

Authors:  Jennifer N Mahon; Kelly J Rohan; Yael I Nillni; Michael J Zvolensky
Journal:  Arch Womens Ment Health       Date:  2014-10-01       Impact factor: 4.405

Review 6.  What Pre-clinical Rat Models Can Tell Us About Anxiety Across the Menstrual Cycle in Healthy and Clinically Anxious Humans.

Authors:  Jodie E Pestana; Nusaibah Islam; Natasha L Van der Eyk; Bronwyn M Graham
Journal:  Curr Psychiatry Rep       Date:  2022-10-18       Impact factor: 8.081

7.  The role of emotion regulation in the experience of menstrual symptoms and perceived control over anxiety-related events across the menstrual cycle.

Authors:  Sanjana Manikandan; Yael I Nillni; Michael J Zvolensky; Kelly J Rohan; Krystle R Carkeek; Teresa M Leyro
Journal:  Arch Womens Ment Health       Date:  2016-08-25       Impact factor: 3.633

Review 8.  Determining menstrual phase in human biobehavioral research: A review with recommendations.

Authors:  Alicia M Allen; Aimee L McRae-Clark; Samantha Carlson; Michael E Saladin; Kevin M Gray; Cora Lee Wetherington; Sherry A McKee; Sharon S Allen
Journal:  Exp Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.157

9.  Metabotropic glutamate receptor subtype 5 (mGlu5) is necessary for estradiol mitigation of light-induced anxiety behavior in female rats.

Authors:  Christiana K Miller; Amanda A Krentzel; Heather B Patisaul; John Meitzen
Journal:  Physiol Behav       Date:  2019-12-09

Review 10.  Suicide Risk and the Menstrual Cycle: a Review of Candidate RDoC Mechanisms.

Authors:  Sarah A Owens; Tory Eisenlohr-Moul
Journal:  Curr Psychiatry Rep       Date:  2018-10-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.